[Contribution on the therapy of progressive chronic polyarthritis with antimetabolites and cytostatics].
D000293:Adolescent; D000963:Antimetabolites / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D013585:Synovitis / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use
D000963:Antimetabolites; D000970:Antineoplastic Agents; D013852:Thiotepa; D001623:Betamethasone; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate
Beitrag zur Behandlung der progredient chronischen Polyarthritis mit Antimetaboliten und Cytostatica.